No Detail Found!

Comparison of Hydralazine and Nifedipine for Severe Hypertension in Pregnancy.

Author(s)
JAWERIA FAISAL Al-Nafees Medical College & Hospital, Isra University, Islamabad Campus, Pakistan
ZEBA MUNZAR Al-Nafees Medical College & Hospital, Isra University, Islamabad Campus, Pakistan
TOOBA RIAZ Nawaz Sharif Social Security Hospital, Multan Road Lahore, Pakistan
NUSRAT JUNJUA Al-Nafees Medical College & Hospital, Isra University, Islamabad Campus, Pakistan
Abstract
OBJECTIVE: To compare efficacy and safety of Hydralazine and Nifedipine in management of hypertension in pregnancy. STUDY DESIGN: A Randomized control trial. PLACE AND DURATION: Mother and Child Health Unit II, PIMS, Islamabad, from 1st January 2007 to 1st July 2007. METHODOLOGY: Sixty patients of hypertension beyond 28 weeks of gestation were recruited for study after informed consent. The registered subjects were randomly allocated to Hydralazine group and Nifedipine group by using random number table. Blood pressure was checked in supine position on right arm before initiating treatment and thereafter checked at ½ hour, 1 hour, 1½ hour and 2 hours. Patients were observed for side effects of drugs. RESULTS: The mean initial Blood pressure was 170/113 mmHg. Time for effective control of systolic BP was 1 hour in Nifedipine group and 1 ½ in Hydralazine group. Time taken for control of diastolic BP was same in both groups i.e. 1 hour. The mean prolongation of pregnancy was 4.5 days in Nifedipine group and 2 days in Hydralazine group with a significant difference of p value .02. Fewer doses were required in Nifedipine group. Hydralazine was more associated with palpitation (56%), flushing (56%), persistent Hypertension (HTN) (16.7%) and tachycardia > 110 bpm (20%). There was no significant difference in other variables measuring fetomaternal outcome except that Nifedipine caused headache in 73% patients after drug administration. CONCLUSION: Nifedipine is more effective for control of Hypertension (HTN) in pregnancy.
Publication Details
Page(s) 3-8
DOI DOI not available
Published Journal: Isra Medical Journal, Volume: 9, Issue: 1, Year: 2017

Request the full text from PASTIC

References
WalfischA,HallakM.,Hypertension,JamesDK,SteerPJ,WeinerCP, 2006.,High Risk Pregnancy Management Options. 3rd ed. Philadelphia: Elsevier 772 -89
MageeLA,AbalosE,DadelszenPV,SibaiB,EasterlingT,WalkinshawS., 2011.How to manage hypertension in pregnancy effectively,Br Clin Pharmacol 72 394 -401
KilpatrickSJ,AbreoA,GreeneN,MelsopK,PetersonN,ShieldsLE, 2016.Severe maternal morbidity in a large cohort of women with acute severe intrapartum hypertension,Am J Obs Gynecol 215 1 -7
LoJO,MissionJF,CaugheyAB, 2013.Hypertensive disease of pregnancy and maternal mortality,Curr Opin Obs Gynecol 25 124 -32
MutzeS,Rudnik-SchonebornS,ZerresK,RathW., 2008.Genes and the preeclampsia syndrome,J Perinat Med 36 38 -58
VadheraRB,SimonM., 2014.Hypertensive emergencies in pregnancy,Clin Obstet Gynecol 57 797 -805
TFiroz,K MacDonell,RGordon,MVidler, 2014.Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review BJOG, 121 1210 -18
ShennanA,LuesleyDM,BakerPN, 2010.Obstetrics and Gynaecology An evidence-based text for MRCOG,2nded. London : Edward Arnold pp184 -91
BridgesEJ,WombleS,WallaceM,McCartneyJ, 2003.Hemodynamic monitoring in high-risk obstetrics patients, II Pregnancy induced hypertension and preeclampsia,Crit Care Nurse 23 52 -57
ZeidmanLA,VidenovicA,BernsteinLP, 2005.Lethal pontine hemorrhage in postpartum syndrome of hemolysis, elevated liver enzyme levels, and low platelet count,Arch Neurol 62 1150 -53
ShennanA, 2007.Dewhurst's text book of obstetrics and gynaecology,7th ed. Oxford: Blackwell Science 227 -35
ChohanMA, 2005., 57 -75
ShekharS,GuptaN,KirubakaranR, 2016.Oral nifedipine versus intravenous labetalol for severe hypertension during pregnancy: a systematic review and meta-analysis,BJOG 123 40 -47
VaronJ,MarikPE, 2000.The Diagnosis and Management of Hypertensive Crises,Chest 118 214 -27
CheemaMA, 2000.Therapeutics of drugs acting on CNS & CVS,National Medical Publications Lahore 148 -
2001.B e n o w i t z N L . C a rd i o va s c u l a r - Re n a l D r u g s : Antihypertensive agents,In: Katzung BG. Basic and Clinical Pharmacology. 8thed. New York: McGraw Hill 155 -80
AaliBS,NejadSS, 2002.Nifedipine or Hydralazine as a first -line agent to control hypertension in severe preeclampsia,Acta Obstet Gynecol Scand 81 25 -30
KhedunSM,MoodleyJ,NaickerT,MaharajB, 1997.Drug management of hypertensive disorders of pregnancy,Pharmacol Ther 74 221 -58
MunimTF, 2002.Management of Eclampsia by diazepam infusion and oral nifedipine,J Surg Pak Mar 7 10 -13
MageeLA,ChamC,WatermanEJ,OhlssonA,DadelszenPV, 2003.Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis,BMJ 327 955 -64
KatzungBJ, 2001.Chatter jee K. Cardiovascular - Renal Drugs: vasodilators and the treatment angina pectoris,Basic and clinical pharmacology.8th ed. New York: McGraw Hill 81 -99
NomburLI,AgidaET,IsahAY,EkeleBA, 2014.A comparison of hydralazine and labetalol in the management of severe preeclampsia,J Womens Health Care 3 1 -4
LewM,KlonisE, 2003.Emergency management of eclampsia and severe pre-eclampsia,Emerg Med 15 361 -68
CunninghamFG,GantNF,LevenoKJ,GilstrapLC,HauthJC,WenstromKD, 2001.Hypertensive disorders in pregnancy,Williams Obstetrics. 21sted. New York: McGraw Hill 567 -618
BrosensI,BenagianoG,BrosensJJ, 2015.The potential perinatal origin of placentation disorders in the young primigravida,Am J Obstet Gynecol 212 580 -85
ShekharS,SharmaC,ThakurS,VermaS., 2013.Oral nifedipine or intravenous labetalol for hypertensive emergency in pregnancy: a randomized controlled trial,Obstet Gynecol 122 1057 -63
BegumMR,QuadirE,BegumA,AkhterS,RahmanK., 2002.Management of hypertensive emergencies of pregnancy by hydralazine bolus injection vs continuous drip -a comparative study,Medscape Women's Health 7 1 -
DuleyL,MeherS, 2013.Drugs for treatment of very high blood pressure during pregnancy,Cochrane Database Syst Rev 31 -
PasqualeSDD,VelardeR,ReyesO,OssaKDL, 2014.Hydralazine vs labetalol for the treatment of severe hypertensive disorders of pregnancy. A randomized, controlled trial,Pregnancy Hypertension, An Inter J Womens Cardiovascular Health 4 19 -22
ClfkovaR., 2006.Hypertension in pregnancy,Vnitr 52 263 -70
MaharajB,KhedunSM,MoodleyJ,BylKVD,RapitiN., 1997.A comparative study of intravenous isradipine and dihydralazine in the treatment of severe hypertension of pregnancy in black patients,Hypertension in pregnancy 16 1 -9
GraciaP VE,LassoM,RuizE,Vega-MalekJC,de MenaFT,LópezJC, 2006.Severe hypertension in pregnancy: hydralazine or labetalol. A randomized clinical trial,Eur J Obs Gynecol Reprod Biol 128 157 -62
ParukF,MoodleyJ, 2000.Treatment of severe preeclampsia /eclampsia syndrome,Progress in obstetrics and gynaecology 14 102 -19
FenakelK,FenakelG,AppelmanZ,LurieS,KatzZ, 1991.Nifedipine in the treatment of severe preeclampsia,Obstetrics and Gynecology 77 331 -37
0

Citations

0

Downloads

122

Views